Enrofloxacin/BSA is an antigen-adjuvant conjugate consisting of Enrofloxacin and bovine serum albumin (BSA). This conjugation enhances the production of antigen-specific antibodies in vaccine models without affecting protein folding or disrupting major epitopes. Additionally, it boosts cross-presentation and the generation of antigen-specific T cells.